{"id":1688,"date":"2021-06-04T09:46:25","date_gmt":"2021-06-04T01:46:25","guid":{"rendered":"https:\/\/www.cfoh.org.tw\/?page_id=1688"},"modified":"2021-06-04T09:46:45","modified_gmt":"2021-06-04T01:46:45","slug":"case-2","status":"publish","type":"page","link":"https:\/\/www.cfoh.org.tw\/index.php\/nbs\/case\/case-2\/","title":{"rendered":"\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7 (CAH) \u81e8\u5e8a\u6848\u4f8b\u5206\u4eab"},"content":{"rendered":"\n<p style=\"text-align: center;\"><strong>\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f<\/strong><br \/><strong>\u81fa\u5317\u69ae\u6c11\u7e3d\u91ab\u9662 \u5152\u7ae5\u907a\u50b3\u5167\u5206\u6ccc\u79d1 \u694a\u4f73\u9cf3 \u91ab\u5e2b<\/strong><br \/><strong>\u81fa\u5317\u69ae\u6c11\u7e3d\u91ab\u9662 \u5167\u5206\u6ccc\u65b0\u9673\u4ee3\u8b1d\u79d1 \u6797\u5b8f\u9054 \u91ab\u5e2b<\/strong><br \/><strong>\u672c\u6587\u539f\u6587\u520a\u8f09\u65bc\u4e2d\u83ef\u6c11\u570b\u5167\u5206\u6ccc\u5b78\u6703\u51fa\u7248\u4e4b\u300c\u814e\u4e0a\u817a\u75be\u75c5\u65b0\u77e5\u300d<\/strong><\/p>\n<p style=\"text-align: justify;\">\u4e00\u3001\u524d\u8a00<br \/>\u3000\u3000\u814e\u4e0a\u817a\u5206\u9ad3\u8cea\u8207\u76ae\u8cea\u5169\u90e8\u4efd\u3002\u9ad3\u8cea\u4e3b\u8981\u5206\u6ccc\u61c9\u4ed8\u7dca\u6025\u58d3\u529b\u6709\u4ea4\u611f\u795e\u7d93\u4f5c\u7528\u7684\u814e\u4e0a\u817a\u7d20(epinephrine)\u548c\u6b63\u814e\u4e0a\u817a\u7d20 (norepinephrine)\uff1b\u76ae\u8cea\u5247\u5206\u6ccc\u76ae\u8cea\u9187 (cortisol)\u3001\u919b\u56fa\u916e (aldosterone)\u4ee5\u53ca\u5404\u7a2e\u96c4\u6027\u8377\u723e\u8499\u5982\u812b\u6c2b\u8868\u96c4\u56fa\u916e (dehydroepiandrosterone, DHEA)\uff0c\u96c4\u56fa\u70ef\u4e8c\u916e (androstenedione)\u548c\u776a\u56fa\u916e (testosterone)\u7b49\u3002\u76ae\u8cea\u9187\u4e3b\u8981\u529f\u80fd\u662f\u61c9\u4ed8\u58d3\u529b\u3001\u5347\u7cd6\u4e26\u8207\u514d\u75ab\u529f\u80fd\u6709\u95dc\u3002\u919b\u56fa\u916e\u5247\u4f5c\u7528\u65bc\u814e\u81df\u9060\u7aef\u7d30\u5c3f\u7ba1\uff0c\u589e\u52a0\u9209\u96e2\u5b50\u7684\u518d\u5438\u6536\uff0c\u6392\u6cc4\u9240\u548c\u6c2b\u96e2\u5b50\uff0c\u4f7f\u8840\u58d3\u4e0a\u5347\u3002\u81bd\u56fa\u9187\u662f\u6240\u6709\u814e\u4e0a\u817a\u76ae\u8cea\u8377\u723e\u8499\u7684\u524d\u9a45\u7269\u8cea\uff0c\u7d93\u904e\u4e00\u9023\u4e32\u9175\u7d20\u7684\u4f5c\u7528\u800c\u751f\u6210\u5404\u7a2e\u76ae\u8cea\u8377\u723e\u8499\u3002\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7 (Congenital adrenal hyperplasia, CAH)\u70ba\u4e00\u67d3\u8272\u9ad4\u96b1\u6027\u907a\u50b3\u75be\u75c5\uff0c\u6839\u64da\u4e0d\u540c\u985e\u578b\u548c\u4e0d\u540c\u7a0b\u5ea6\u7684\u985e\u56fa\u9187\u751f\u6210\u963b\u6eef\uff0c\u60a3\u8005\u6703\u6709\u76ae\u8cea\u9187\u3001\u919b\u56fa\u916e\u548c\u96c4\u6027\u8377\u723e\u8499\u7570\u5e38\u7684\u8868\u73fe\u3002\u5148\u5929\u6027\u814e\u4e0a\u817a\u76ae\u8cea\u589e\u751f\u75c7\u5305\u62ec\u4e0b\u9762\u5e7e\u7a2e\u985e\u578b\uff0c\u5176\u4e2d\u8d85\u904e\u767e\u5206\u4e4b\u4e5d\u5341\u70ba\u985e\u56fa\u918721-\u7fa5\u5316\u9176 (Steroid 21-hydroxylase, 21-OH) CYP21A2\u7684\u57fa\u56e0\u8b8a\u7570\u800c\u5f15\u8d77\u3002<br \/>1. 21-\u7fa5\u5316\u9176 (21-hydroxylase, 21-OH)<br \/>2.11\u03b2-\u7fa5\u5316\u9176 (11\u03b2-hydroxylase, 11\u03b2-OH)<br \/>3.17\u03b1-\u7fa5\u5316\u9176 (17 \u03b1-hydroxylase, 17-OH\uff1balso known as 17,20-lyase)<br \/>4. \u7b2c 2 \u578b 3\u03b2-\u7fa5\u985e\u56fa\u9187\u53bb\u6c2b\u9176 (3\u03b2-hydroxysteroid dehydrogenase type 2, 3\u03b2-HSD2)<br \/>5. \u985e\u56fa\u9187\u751f\u6210\u6025\u6027\u8abf\u63a7\u86cb\u767d (Steroidogenic acute regulatory protein, StAR)<br \/>6. P450 \u81bd\u56fa\u9187\u5074\u93c8\u88c2\u89e3\u9176 (P450 cholesterol side-chain cleavage enzyme, SCC)<\/p>\n<p style=\"text-align: justify;\">\u4e8c\u3001\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\uff0c21-\u7fa5\u5316\u9176 (21-OH)\u7f3a\u4e4f<br \/>\u3000\u3000\u6700\u5e38\u898b\u7684\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\uff0c\u70ba21-\u7fa5\u5316\u9176 (21-OH)\u7f3a\u4e4f\uff0c\u7576\u814e\u4e0a\u817a\u56e021-\u7fa5\u5316\u9176\u7f3a\u4e4f\uff0c\u7121\u6cd5\u5408\u6210\u76ae\u8cea\u9187\u53ca\u919b\u56fa\u916e\u6642\uff0c\u524d\u9a45\u7269\u8cea17-\u7fa5\u52a9\u5b55\u916e (17-hydroxyproges-terone, 17-OHP)\u6703\u5347\u9ad8\uff0c\u4e5f\u5c0e\u81f4\u4fc3\u814e\u4e0a\u817a\u76ae\u8cea\u7d20 (adrenocorticotropic hormone, ACTH)\u5347\u9ad8\uff0c\u4fc3\u4f7f\u814e\u4e0a\u817a\u589e\u751f\u80a5\u5927\uff0c\u4e26\u4e14\u5f80\u96c4\u6027\u8377\u723e\u8499\u65b9\u5411\u88fd\u9020\uff0c\u4f7f\u8eab\u9ad4\u7522\u751f\u904e\u591a\u7684\u96c4\u6027\u8377\u723e\u8499\uff0c\u9020\u6210\u5973\u5b30\u6703\u6709\u534a\u9670\u967d\u5916\u751f\u6b96\u5668\uff0c\u5982\u9670\u8482\u80a5\u5927\uff1b\u7537\u5b30\u5247\u53ef\u80fd\u51fa\u73fe\u9670\u56ca\u8272\u6df1\u7684\u75c7\u72c0\uff0c21-\u7fa5\u5316\u9176 (21-OH)\u7f3a\u4e4f\u7684\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\u662f\u4f7f\u65b0\u751f\u5152\u5916\u9670\u6027\u5225\u4e0d\u660e\u7684\u6700\u5e38\u898b\u539f\u56e0\u3002\u5169\u6027\u5747\u53ef\u80fd\u51fa\u73fe\u6bdb\u9aee\u589e\u751f\u75c7\u72c0\u8f14\u4ee5\u975e\u7279\u7570\u7684\u80c3\u8178\u75c7\u72c0\uff0c\u5982\uff1a\u812b\u6c34\u3001\u8179\u7009\u3001\u5614\u5410\u3001\u98df\u617e\u4e0d\u632f\u4f86\u8868\u73fe\u3002\u5178\u578b\u7684\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\u5206\u70ba\u300c\u5931\u9e7d\u578b\u300d(salt-wasting type)\u548c\u300c\u55ae\u7d14\u96c4\u6027\u5316\u578b\u300d(simple-virilizing type)\u3002\u5927\u7d043\/4\u7684\u60a3\u8005\u662f\u5c6c\u65bc\u300c\u5931\u9e7d\u578b\u300d\uff0c\u6703\u767c\u751f\u9ad8\u8840\u9240\u3001\u4f4e\u8840\u9209\u3001\u812b\u6c34\u8207\u4ee3\u8b1d\u6027\u9178\u4e2d\u6bd2\uff0c\u901a\u5e38\u6703\u65bc\u51fa\u751f\u5169\u9031\u5167\u767c\u751f\uff0c\u5982\u679c\u672a\u80fd\u53ca\u6642\u6cbb\u7642\uff0c\u6975\u53ef\u80fd\u56e0\u6025\u6027\u814e\u4e0a\u817a\u6a5f\u80fd\u4e0d\u5168\uff0c\u814e\u4e0a\u817a\u5371\u8c61\u800c\u6b7b\u4ea1\u3002<br \/>\u3000\u3000\u975e\u5178\u578b (non-classical or late-onset type)\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\uff0c\u60a3\u8005\u9175\u7d20\u6d3b\u6027\u7f3a\u4e4f\u8f03\u8f15\u5fae\uff0c\u53ef\u80fd\u51fa\u73fe\u591a\u6bdb\u3001\u6708\u7d93\u4e0d\u9806\u3001\u9577\u75d8\u75d8\u2026\u7b49\u7b49\u7684\u7537\u6027\u5316(virilization)\u75c7\u72c0\uff0c\u5408\u4f75\u9aa8\u9f61\u8d85\u524d\u3001\u6027\u65e9\u719f\u3002\u9019\u4e9b\u60a3\u8005\u9700\u5b9a\u6642\u8ffd\u8e64\u8840\u6db2\u4e2d17-\u7fa5\u52a9\u5b55\u916e\u3001\u776a\u56fa\u916e\u7684\u6fc3\u5ea6\uff0c\u4ee5\u4f5c\u70ba\u6cbb\u7642\u7684\u8a55\u4f30\u4f9d\u64da\uff0c\u66f4\u9700\u5bc6\u5207\u6ce8\u610f\u60a3\u8005\u6574\u9ad4\u7684\u767c\u5c55\uff0c\u5305\u542b\u7b2c\u4e8c\u6027\u5fb5\u767c\u80b2\u7a0b\u5ea6\u4ee5\u53ca\u9aa8\u9f61\u7684\u8a55\u4f30\uff0c\u4ee5\u514d\u51fa\u73fe\u6027\u65e9\u719f\uff0c\u9020\u6210\u60a3\u8005\u6210\u4eba\u8eab\u9ad8\u4e0d\u5982\u9810\u671f\u3002\u76ee\u524d\u5728\u8eab\u9ad8\u53ca\u6027\u65e9\u719f\u6cbb\u7642\u65b9\u9762\uff0c\u5408\u4f75\u6027\u8377\u723e\u8499\u6291\u5236\u5291\u548c\u751f\u9577\u6fc0\u7d20\uff0c\u81e8\u5e8a\u4e0a\u78ba\u5be6\u80fd\u5728\u751f\u9577\u677f\u5bc6\u5408\u524d\u6539\u5584\u60a3\u8005\u8eab\u9ad8\u3002<br \/>\u3000\u3000\u96d6\u7136\u53f0\u7063\u5df2\u65bc80\u5e74\u4ee3\u8d77\uff0c\u5168\u9762\u5be6\u65bd\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\u65b0\u751f\u5152\u7be9\u6aa2\uff0c\u4ecd\u53ef\u80fd\u907a\u6f0f\u975e\u5178\u578b\u7684\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\u6b64\u985e\u6bd4\u8f03\u8f15\u75c7\u75c5\u60a3\u3002\u5982\u679c\u6b64\u985e\u75c5\u4eba\u8a3a\u65b7\u6642\uff0c\u751f\u9577\u677f\u5df2\u5bc6\u5408\uff0c\u8eab\u9ad8\u4e0a\u81e8\u5e8a\u53ef\u80fd\u7121\u6cd5\u63d0\u4f9b\u5177\u9ad4\u7684\u5e6b\u52a9\u3002\u975e\u5178\u578b\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\u7684\u6210\u4eba\u5973\u6027\u60a3\u8005\u53ef\u80fd\u51fa\u73fe\u591a\u6bdb\u3001\u6708\u7d93\u5931\u8abf\u4ee5\u53ca\u4e0d\u5b55\u7684\u554f\u984c\uff0c\u6709\u6642\u5bb9\u6613\u88ab\u8aa4\u8a3a\u70ba\u591a\u56ca\u6027\u5375\u5de2\u75c7\u5019\u7fa4\uff0c\u91dd\u5c0d\u6b64\u985e\u60a3\u8005\u9664\u4e86\u6aa2\u9a57\u8840\u4e2d\u76f8\u95dc\u751f\u5316\u503c\u7684\u6fc3\u5ea6\u53ca\u57fa\u56e0\u78ba\u8a3a\u5916\uff0c\u4e5f\u9700\u8003\u616e\u76f8\u95dc\u6cbb\u7642\uff1a\u6708\u7d93\u5931\u8abf\u53ef\u4f7f\u7528\u53e3\u670d\u8377\u723e\u8499\u4f86\u7dad\u6301\u6b63\u5e38\u5468\u671f\uff1b\u56e0\u96c4\u6027\u6fc0\u7d20\u904e\u9ad8\u7121\u6cd5\u6392\u5375\u800c\u9020\u6210\u7684\u4e0d\u5b55\uff0c\u5247\u61c9\u4f7f\u7528\u4fc3\u9032\u6392\u5375\u7684\u76f8\u95dc\u6cbb\u7642\u3002<br \/>\u3000\u3000\u7be9\u6aa217-\u7fa5\u52a9\u5b55\u916e (17-OHP)\u6fc3\u5ea6\u5347\u9ad8\u7684\u65b0\u751f\u5152\u5178\u578b (\u56b4\u91cd\u578b)21-\u7fa5\u5316\u9176 (21-OH)\u7f3a\u4e4f\u75c7\uff0c\u5728\u8a31\u591a\u570b\u5bb6\u90fd\u5df2\u5be6\u884c\u591a\u5e74\uff0c\u7576\u75c5\u60a3\u56e0\u65b0\u751f\u5152\u7be9\u6aa2\u7591\u4f3c\u70baCAH\u60a3\u8005\uff0c\u63a5\u8457\u9700\u5b89\u6392\u57fa\u56e0\u7be9\u6aa2\u53ca\u907a\u50b3\u8aee\u8a62\uff0c\u6b64\u75c7\u70ba\u9ad4\u67d3\u8272\u9ad4\u96b1\u6027\u907a\u50b3 (autosomal recessive inheritance, AR)\u6a21\u5f0f\uff0c\u6700\u5e38\u898b\u7684\u539f\u56e0\u70ba\u7b2c\u516d\u865f\u67d3\u8272\u9ad4\u4e0a\u7684CYP21\u57fa\u56e0\u6709\u7f3a\u9677\u3002\u592b\u59bb\u96d9\u65b9\u5747\u70ba\u5e36\u56e0\u8005\uff0c\u5176\u5b50\u5973\u5247\u670925%\u7684\u6a5f\u7387\u6b63\u5e38\uff0c25%\u7684\u6a5f\u7387\u6703\u7f79\u75c5\uff0c50%\u7684\u6a5f\u7387\u8207\u7236\u6bcd\u4e00\u6a23\u662f\u5e36\u56e0\u8005\u3002\u5be6\u9a57\u5ba4\u53ef\u6aa2\u6e2c\u8840\u4e2d\u76ae\u8cea\u9187\u3001\u96c4\u6027\u7d20 (androgen)\u548c\u4fc3\u814e\u4e0a\u817a\u76ae\u8cea\u7d20\u4ee5\u53ca17-\u7fa5\u52a9\u5b55\u916e\u9032\u884c\u9032\u4e00\u6b65\u78ba\u8a8d\u300221-\u7fa5\u5316\u9176 (21-OH)\u50ac\u5316\u81bd\u56fa\u9187\u4e4b\u4ee3\u8b1d\u53cd\u61c9\u50c5\u5728\u814e\u4e0a\u817a\u76ae\u8cea\u5c64\u9032\u884c\uff0c\u5f9e\u8840\u6db2\u6216\u4efb\u4f55\u9ad4\u6db2\u5747\u7121\u6cd5\u5075\u6e2c21-\u7fa5\u5316\u9176 (21-OH)\u7684\u6d3b\u6027\uff0c\u56e0\u6b64\u7121\u6cd5\u85c9\u7531\u5e38\u898f\u7684\u751f\u5316\u6aa2\u67e5\u6aa2\u6e2c21-\u7fa5\u5316\u9176 (21-OH)\u6fc3\u5ea6\uff0c\u6545\u6539\u70ba\u5075\u6e2c\u4ee3\u8b1d\u904e\u7a0b\u4e2d\u4e4b\u4e2d\u9593\u7269\u8cea17-\u7fa5\u52a9\u5b55\u916e\u3002\u65b0\u751f\u5152\u7be9\u6aa2\u7d93\u7531\u624e\u8840\u65bc\u8840\u7247\uff0c\u6aa2\u9a5717-\u7fa5\u52a9\u5b55\u916e\u6fc3\u5ea6\u662f\u5426\u504f\u9ad8\u9032\u884c\u521d\u6b65\u6aa2\u67e5\uff0c\u4f46\u56e0\u8a31\u591a\u56e0\u7d20\u6703\u9020\u6210\u5047\u6027\u4e0a\u5347\u5982\u65e9\u7522\u5152\u2026\u7b49\uff0c\u6240\u4ee5\u4ecd\u9700\u7d93\u904e\u6aa2\u6e2c\u8840\u4e2d\u76ae\u8cea\u9187\u3001\u96c4\u6027\u7d20\u548c\u4fc3\u814e\u4e0a\u817a\u76ae\u8cea\u7d20 (ACTH)\u4ee5\u53ca17-\u7fa5\u52a9\u5b55\u916e\u548c\u57fa\u56e0\u6aa2\u6e2c\u624d\u80fd\u78ba\u8a8d\u3002<br \/>\u3000\u3000\u5404\u570b\u5bb6\u5730\u5340\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\u767c\u751f\u7387\u4e0d\u540c\uff0c\u6700\u9ad8\u7684\u4e8c\u500b\u5730\u5340\u5206\u5225\u662f\u963f\u62c9\u65af\u52a0\u7684Yupik Eskimos \u5730\u5340\u7684 1:282 \uff1b\u6cd5\u570b La Reunion \u5730\u5340\u7684 1:2,141\u3002\u64da\u53f0\u7063 2002-2006\u5e74\u7d71\u8a08\uff0c\u767c\u751f\u7387\u70ba1\/20,800\uff0c\u5982\u4ee5\u6bcf\u5e74\u4e8c\u5341\u842c\u540d\u65b0\u751f\u5152\u7d71\u8a08\u7b97\uff0c\u6bcf\u5e74\u61c9\u53ef\u80fd\u767c\u73fe10\u500b\u75c5\u4f8b\u3002<\/p>\n<p style=\"text-align: justify;\">\u4e09\u3001\u57fa\u56e0\u8207\u7a81\u8b8a\u7684\u4ecb\u7d39<br \/>\u3000\u3000\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7 (CAH)\u5305\u62ec\u4e0b\u9762\u5e7e\u7a2e\u985e\u578b\uff1a21-\u7fa5\u5316\u9176(21-OH)\u300111\u03b2-\u7fa5\u5316\u9176(11\u03b2-OH)\u300117\u03b1-\u7fa5\u5316\u9176(17-OH)\u3001\u7b2c2\u578b3\u03b2-\u7fa5\u985e\u56fa\u9187\u53bb\u6c2b\u9176(3\u03b2-HSD2)\u3001\u985e\u56fa\u9187\u751f\u6210\u6025\u6027\u8abf\u63a7\u86cb\u767d (StAR)\u3001P450\u81bd\u56fa\u9187\u5074\u93c8\u88c2\u89e3\u9176 (SCC)\u4ee5\u53caP450\u6c27\u5316\u9084\u539f\u9176 (P450 oxidoreductase, POR)\u300221-\u7fa5\u5316\u9176\u7f3a\u4e4f\u662f\u6700\u5e38\u898b\u9020\u6210\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u7684\u539f\u56e0\uff0c\u5df2\u5982\u524d\u8ff0\u3002\u4e0b\u6587\u5c31\u4ee5\u6b64\u985e\u578b\u4f86\u4ecb\u7d39\u3002<\/p>\n<p style=\"text-align: justify;\"><a href=\"http:\/\/www.cfoh.org.tw\/wp-content\/uploads\/2021\/06\/CAH-1-1.png\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-1689\" src=\"http:\/\/www.cfoh.org.tw\/wp-content\/uploads\/2021\/06\/CAH-1-1.png\" alt=\"\" width=\"693\" height=\"500\" srcset=\"https:\/\/www.cfoh.org.tw\/wp-content\/uploads\/2021\/06\/CAH-1-1.png 693w, https:\/\/www.cfoh.org.tw\/wp-content\/uploads\/2021\/06\/CAH-1-1-300x216.png 300w\" sizes=\"(max-width: 693px) 100vw, 693px\" \/><\/a>\u5716\u4e00\u3001\u814e\u4e0a\u817a\u985e\u56fa\u9187\u751f\u5408\u6210\u4e4b\u8def\u5f91\u3002<br \/>(A) \u5178\u578b\u985e\u56fa\u9187\u751f\u6210(steroidogenesis)\u8def\u5f91\u4ee5\u53ca\u66ff\u4ee3\u8def\u5f91 (\u6dfa\u9ec3\u5e95\u7684\u90e8\u5206)<br \/>(B) 21-\u7fa5\u5316\u9176(21-OH)\u7f3a\u4e4f\u6642\u7684\u985e\u56fa\u9187\u5408\u6210\u8def\u5f91\u3002<br \/>(\u8cc7\u6599\u4f86\u6e90: El-Maouche D, Arlt W, Merke DP. Congenital Adrenal Hyperplasia. Lancet 2017;390:2194.)<\/p>\n<p style=\"text-align: justify;\">\u3000\u300021-\u7fa5\u5316\u9176(21-OH)\u57fa\u56e0\u5b58\u5728\u65bc\u7b2c\u516d\u5c0d\u67d3\u8272\u9ad4\u4e4b6p21.3\u8655\uff0c\u5206\u5225\u8207class III\u4e3b\u8981\u7d44\u7e54\u76f8\u5bb9\u6027\u8907\u5408\u9ad4 (Human Histocompatibility Complex, MHC)\u4e4b\u88dc\u9ad4 (complement) C4\u57fa\u56e0\u4ea4\u4e92\u4e26\u5b58\uff0c\u7c21\u7a31C4-CYP21 repeat module\u300221-\u7fa5\u5316\u9176 (21-OH)\u5206\u6ccc\u4e0d\u8db3\uff0c\u548cCYP21A2\u57fa\u56e0\u7a81\u8b8a\u6709\u95dc\u3002\u6b64p21.3\u4f4d\u7f6e\u9664\u542b\u6709\u88dc\u9ad4C4\u57fa\u56e0\uff0c\u9084\u6709RP (STK29)\u3001CYP21\u3001TNX\u7b49\u57fa\u56e0\u3002\u9019\u4e9b\u57fa\u56e0\u4ea4\u4e92\u4e26\u5b58\uff0c\u6392\u5217\u6210\u6700\u5e38\u898b\u7684\u96d9\u57fa\u56e0\u675f (RCCX bimodule)\uff0c\u5f62\u6210\u6240\u8b02 RP1-C4A-CYP21P-XA-RP2-C4B-CYP21-XB \u4e4b\u57fa\u56e0\u6392\u5217\uff0c\u6216\u7a31C4-CYP21 repeat module (R \u8868\u793aRP\u3001C \u8868\u793aC4 \u8207CYP21\u3001X \u8868\u793aXA )\u3002\u5728\u67d3\u8272\u9ad4p21.3\u8655\u6709\u4e8c\u500bP450c21\u57fa\u56e0\u5b58\u5728\uff1b\u5047\u6027\u57fa\u56e0 (CYP21A1P, pseudogene)\u8207\u6d3b\u6027\u57fa\u56e0 (CYP21A2, genuine gene)\u3002\u5047\u6027\u57fa\u56e0\u5e8f\u5217\u670995%\u8207CYP21A2\u57fa\u56e0\u76f8\u540c\u3002<br \/>\u3000\u3000\u5728\u7cbe\u3001\u5375\u7d30\u80de\u884c\u6e1b\u6578\u5206\u88c2(meiosis)\u7684\u904e\u7a0b\u4e2d\uff0cCYP21A2\u57fa\u56e0\u53ef\u7522\u751f\u4ea4\u63db (crossover)\uff0c\u4e26\u53ef\u80fd\u767c\u751f\u518d\u91cd\u7d44 (recombination)\u3002\u56e0\u6b64\uff0c\u5f15\u8d77CYP21A2\u57fa\u56e0\u8b8a\u7570\u7684\u56e0\u7d20\u53ef\u5206\u70ba\u4e09\u7a2e\uff1a<br \/>1. \u7d93\u7531\u5047\u6027\u57fa\u56e0\u7a81\u8b8a\u9ede\u5c0f\u7247\u6bb5\u4ea4\u63db\u3002<br \/>2. \u81ea\u7136\u7a81\u8b8a (spontaneous mutation)\u3002<br \/>3. \u6df7\u5408\u57fa\u56e0\u578b (chimeric CYP21P\/CYP21 \u8207 TNXA\/TNXB)\u3002<\/p>\n<p style=\"text-align: justify;\"><a href=\"http:\/\/www.cfoh.org.tw\/wp-content\/uploads\/2021\/06\/CAH-1-2.png\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-1690\" src=\"http:\/\/www.cfoh.org.tw\/wp-content\/uploads\/2021\/06\/CAH-1-2.png\" alt=\"\" width=\"722\" height=\"257\" srcset=\"https:\/\/www.cfoh.org.tw\/wp-content\/uploads\/2021\/06\/CAH-1-2.png 722w, https:\/\/www.cfoh.org.tw\/wp-content\/uploads\/2021\/06\/CAH-1-2-300x107.png 300w\" sizes=\"(max-width: 722px) 100vw, 722px\" \/><\/a>\u5716\u4e8c\u3001Bimodular form (RP1-C4A-CYP21P-XA-RP2-C4B-CYP21-TNXB) of the RCCX region of chromosome 6p21.3. (\u8cc7\u6599\u4f86\u6e90: Lee HH. Chimeric CYP21P\/CYP21 and TNXA\/TNXB genes in the RCCX module. Mol Genet Metab 2005; 84:4.)<br \/>\u76ee\u524d\u4ee5\u6b21\u4e16\u4ee3\u5b9a\u5e8f\u6280\u8853 (next generation sequencing, NGS)\u5206\u6790CYP21A2\u57fa\u56e0\u53ef\u5206\u6790\u6240\u6709\u7684\u5916\u986f\u5b50 (exon)\u53ca\u526a\u63a5\u4f4d\u9ede (splicing site)\u662f\u5426\u767c\u751f\u554f\u984c\uff0c\u4f46\u4ecd\u9808\u7d93\u7531\u50b3\u7d71\u7684\u6851\u683c\u5b9a\u5e8f\u65b9\u6cd5(Sanger sequencing)\u9032\u884c\u78ba\u8a8d\u3002<\/p>\n<p style=\"text-align: justify;\">\u3000\u3000\u5178\u578b21-\u7fa5\u5316\u9176 (21-OH)\u7f3a\u4e4f\u75c7\u7684\u5931\u9e7d\u578b\u548c\u55ae\u7d14\u96c4\u6027\u5316\u578b\u5206\u5225\u53cd\u6620\u51fa\u919b\u56fa\u916e\u7f3a\u4e4f\u7684\u56b4\u91cd\u7a0b\u5ea6\u3002\u5931\u9e7d\u578b21-OH\u7f3a\u4e4f\u75c7\uff0c\u5728\u6c92\u6709\u65b0\u751f\u5152\u7be9\u6aa2\u7684\u60c5\u6cc1\u4e0b\uff0c\u6975\u53ef\u80fd\u5728\u51fa\u751f2\u9031\u5167\u767c\u751f\u5371\u53ca\u751f\u547d\u7684\u814e\u4e0a\u817a\u5371\u8c61\u3002\u55ae\u7d14\u96c4\u6027\u5316\u578b\u80ce\u5152\u5728\u5abd\u5abd\u809a\u5b50\u88e1\u6642\uff0c\u6301\u7e8c\u7684\u66b4\u9732\u5728\u904e\u591a\u7684\u96c4\u6027\u7d20\u7576\u4e2d\uff0c\u4f7f\u5973\u5b30\u7522\u751f\u5916\u751f\u6b96\u5668\u7537\u6027\u5316\uff0c\u6b64\u70ba\u6700\u5178\u578b\u7684\u75c7\u72c0\uff1b\u800c\u6c92\u6709\u65e9\u671f\u8a3a\u65b7\u3001\u65e9\u671f\u6cbb\u7642\u7684\u75c5\u60a3\uff0c\u56e0\u96c4\u6027\u7d20\u904e\u591a\u5c07\u5c0e\u81f4\u6027\u65e9\u719f\u75c7\u72c0\u3002\u975e\u5178\u578b\u768421-OH\u7f3a\u4e4f\u75c7\u60a3\u8005\u5247\u4fdd\u7559\u9ad8\u905450%\u7684\u9175\u7d20\u6d3b\u6027\uff0c\u4e26\u4e14\u591a\u6578\u6c92\u6709\u660e\u986f\u7684\u814e\u4e0a\u817a\u529f\u80fd\u4e0d\u5168\uff0c\u4f46\u53ef\u80fd\u6709\u90e8\u5206\u7cd6\u76ae\u8cea\u7d20\u7f3a\u4e4f\u75c7\uff0c\u4e26\u51fa\u73fe\u8f15\u5ea6\u96c4\u6027\u7d20\u904e\u591a\u7684\u75c7\u72c0\u3002<br \/>\u3000\u3000\u5176\u4ed6\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\u5305\u62ec\uff1a11\u03b2-OH\u7f3a\u4e4f\u75c7\u300117-OH\u7f3a\u4e4f\u75c7(CYP17A1\u57fa\u56e0\u96d6\u7136\u53ea\u7de8\u78bc\u4e00\u7a2e\u9176\uff0c\u4f46\u8a72\u9176\u540c\u6642\u8868\u905417\u03b1-\u7fa5\u5316\u9176\u548c17, 20-\u88c2\u5408\u9176\u6d3b\u6027)\u30013\u03b2 -HSD2\u7f3a\u4e4f\u75c7\u3001cytochrome P450 oxidoreductase\u7f3a\u4e4f\u75c7\u3001\u985e\u8102\u6027\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f (lipoid congenital adrenal hyperplasia)\u3001SCC \u7f3a\u4e4f\u75c7 (P450 side-chain cleavage deficiency)\u3002<\/p>\n<p style=\"text-align: justify;\">\u56db\u3001\u6cbb\u7642<br \/>\u3000\u3000\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\u7684\u85e5\u7269\u6cbb\u7642\u5305\u62ec\u4f7f\u7528\u7cd6\u76ae\u8cea\u7d20 (glucocorticoid)\u4ee5\u53ca\u9e7d\u76ae\u8cea\u7d20 (mineralocorticoid)\u9032\u884c\uff1b\u5982\u6709\u9700\u8981\uff0c\u4e5f\u53ef\u65bc17-OH\u7f3a\u4e4f\u75c7\u30013\u03b2-HSD2\u7f3a\u4e4f\u75c7\u3001\u985e\u8102\u6027\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u3001SCC\u7f3a\u4e4f\u75c7\u6216POR\u7f3a\u4e4f\u75c7\uff0c\u9019\u5e7e\u985e\u60a3\u8005\u8eab\u4e0a\u4f7f\u7528\u6027\u8377\u723e\u8499\u88dc\u5145\u7642\u6cd5\u3002\u800c\u6027\u969c\u7919\u60a3\u8005\u4e4b\u751f\u6b96\u5668\u624b\u8853\u5247\u70ba\u8f03\u5177\u722d\u8b70\u4e4b\u7642\u6cd5\uff0c\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\u7d93\u5e38\u9020\u6210\u5b30\u5e7c\u5152\u6027\u5fb5\u4e0d\u660e\uff0c\u7136\u800c\u662f\u5426\u8981\u56e0\u6027\u5fb5\u4e0d\u660e\u800c\u9032\u884c\u6027\u5225\u91cd\u5efa\u6216\u7f6e\u63db\u624b\u8853\u662f\u4e00\u76f8\u7576\u8907\u96dc\u7684\u554f\u984c\u3002\u4e5f\u6709\u7814\u7a76\u6307\u51fa46XX\u7684\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\u60a3\u8005\uff0c\u53ef\u80fd\u56e0\u5f9e\u80ce\u5152\u6642\u671f\u5c31\u66b4\u9732\u5728\u904e\u591a\u7684\u96c4\u6027\u7d20\u4e4b\u4e0b\uff0c\u800c\u6709\u8f03\u9ad8\u7684Lesbian\u50be\u5411\u3002\u76ee\u524d\u5c0d\u65bc\u6027\u5225\u8a8d\u540c\u6b64\u4e00\u8b70\u984c\uff0c\u5c08\u5bb6\u5b78\u8005\u50be\u5411\u7531\u500b\u4eba\u5fc3\u7406\u8a8d\u77e5\u6c7a\u5b9a\uff0c\u4f46\u56e0\u5b69\u7ae5\u6642\u671f\u91ab\u7642\u6c7a\u7b56\u4e4b\u6c7a\u5b9a\u6b0a\u6b78\u5c6c\u4ecd\u76f8\u7576\u8907\u96dc\uff0c\u5efa\u8b70\u7531\u76f8\u95dc\u9818\u57df\u5c08\u5bb6\uff0c\u5055\u540c\u75c5\u60a3\u53ca\u5bb6\u5c6c\u5171\u540c\u8a0e\u8ad6\u6c7a\u5b9a\u3002<br \/>\u3000\u3000\u9664\u6b64\u4e4b\u5916\uff0c\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\u7684\u6cbb\u7642\u6311\u6230\u9084\u5305\u62ec\u5982\u4f55\u907f\u514d\u76ae\u8cea\u9187\u7684\u904e\u5ea6\u6cbb\u7642\uff0c\u4ee5\u53ca\u6027\u6fc0\u7d20\u5931\u8861\u7684\u63a7\u5236\u3002\u9577\u671f\u4f75\u767c\u75c7\u5305\u62ec\u7570\u5e38\u751f\u9577\u767c\u80b2\u3001\u5c0d\u9aa8\u9abc\u548c\u5fc3\u8840\u7ba1\u7cfb\u7d71\u7684\u4e0d\u826f\u5f71\u97ff\u4ee5\u53ca\u4e0d\u5b55\u75c7\u3002\u4ee5\u85e5\u7269\u8a66\u8457\u5e73\u8861\u8eab\u9ad4\u5982\u6b64\u91cd\u8981\u7684\u6fc0\u7d20\u6cbb\u7642\uff0c\u5be6\u70ba\u4e0d\u6613\uff0c\u81e8\u5e8a\u4e0a\u9700\u8981\u76f8\u7576\u4e4b\u6cbb\u7642\u7d93\u9a57\u548c\u75c5\u60a3\u3001\u5bb6\u5c6c\u7684\u9577\u671f\u914d\u5408\uff0c\u76ee\u6a19\u70ba\u6e1b\u5c11\u76ae\u8cea\u9187\u7684\u904e\u5ea6\u66b4\u9732\u548c\u9577\u671f\u88dc\u5145\u7684\u526f\u4f5c\u7528\uff0c\u6539\u5584\u8377\u723e\u8499\u63a7\u5236\uff0c\u4e26\u6a21\u4eff\u751f\u7406\u8377\u723e\u8499\u6a21\u5f0f\u3002\u75c5\u60a3\u9700\u9577\u671f\u89c0\u5bdf\u8a18\u9304\u751f\u9577\u901f\u5ea6\u4e26\u8ffd\u8e64\u9aa8\u9f61\uff0c\u5982\u51fa\u73fe\u751f\u9577\u9072\u6eef\uff0c\u8eab\u6750\u77ee\u5c0f\u5408\u4f75\u6027\u65e9\u719f\uff0c\u81e8\u5e8a\u4e0a\u986f\u793a\u9069\u7576\u6642\u6a5f\u4f7f\u7528\u6027\u8377\u723e\u8499\u6291\u5236\u5291\u5408\u4f75\u751f\u9577\u6fc0\u7d20\uff0c\u65bc\u751f\u9577\u677f\u5bc6\u5408\u524d\u53ef\u6709\u6548\u6539\u5584\u8eab\u9ad8\u3002<br \/>\u7cd6\u76ae\u8cea\u7d20\u7f3a\u4e4f\u70ba\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\u60a3\u8005\u6700\u56b4\u91cd\u7684\u75be\u75c5\u751f\u7406\u554f\u984c\uff0c\u53ef\u80fd\u5a01\u8105\u751f\u547d\u3002\u5728\u745e\u5178\u7684\u4e00\u9805\u7814\u7a76\u4e2d\uff0c\u6709588\u540d\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\u60a3\u8005\uff0c\u75c5\u60a3\u6b7b\u4ea1\u5927\u591a\u56e0\u814e\u4e0a\u817a\u5371\u8c61\u5f15\u8d77\uff0c\u7a81\u51fa\u4e86\u9019\u7a2e\u72c0\u6cc1\u7684\u91cd\u8981\u6027\u3002\u4f46\u60a3\u8005\u9577\u671f\u63a5\u53d7\u7cd6\u76ae\u8cea\u7d20\u6cbb\u7642\u5247\u53ef\u80fd\u5f15\u8d77\u8eab\u6750\u77ee\u5c0f\uff0c\u56e0\u6b64\u7cd6\u76ae\u8cea\u7d20\u88dc\u5145\uff0c\u61c9\u8a72\u4ee5\u76e1\u53ef\u80fd\u4f4e\u7684\u6709\u6548\u5291\u91cf\u70ba\u76ee\u6a19\u3002<br \/>\u3000\u3000\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\u60a3\u8005\u76ee\u524d\u6cbb\u7642\u6548\u679c\u7121\u6cd5\u5341\u5206\u5b8c\u7f8e\uff0c\u53ef\u80fd\u539f\u56e0\u70ba\u8377\u723e\u8499\u5931\u8abf\u6216\u8207\u6cbb\u7642\u76f8\u95dc\u7684\u5408\u4f75\u75c7\uff0c\u56e0\u6b64\u958b\u767c\u65b0\u7642\u6cd5\u7684\u75c5\u7406\u751f\u7406\u5b78\u4ecd\u5728\u6301\u7e8c\u9032\u884c\u4e2d\u3002\u5176\u4e2d\uff0c\u53e3\u670d\u7de9\u91cb\u6c2b\u76ae\u8cea\u916e\u88fd\u5291 (modified-release oral hydrocortisone)\u6210\u529f\u964d\u4f4e\u4e86\u60a3\u8005\u9ad4\u5167\u96c4\u6027\u8377\u723e\u8499\u7684\u6fc3\u5ea6\uff1b\u85c9\u7528\u9023\u7e8c\u80f0\u5cf6\u7d20\u5e6b\u6d66\uff0c\u6a21\u64ec\u665d\u591c\u7bc0\u5f8b\uff0c\u898f\u5f8b\u5730\u76ae\u4e0b\u6ce8\u5c04\u6c2b\u76ae\u8cea\u916e\uff0c\u986f\u793a\u51fa\u5c0dACTH\u7684\u5145\u5206\u6291\u5236\u4ee5\u53ca\u8207\u5e38\u898f\u6cbb\u7642\u76f8\u6bd4\u8f03\u4f4e\u7684\u76ae\u8cea\u916e\u7e3d\u5291\u91cf\u3002\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\u662f\u4e00\u7a2e\u55ae\u57fa\u56e0\u75be\u75c5\uff0c\u56e0\u6b64\uff0c\u57fa\u65bc\u7d30\u80de\u548c\u57fa\u56e0\u7de8\u8f2f\u7684\u57fa\u56e0\u6cbb\u7642\u6280\u8853\u5df2\u7d93\u5728\u814e\u4e0a\u817a\u76ae\u8cea\u6a5f\u80fd\u4e0d\u8db3\u7684\u52d5\u7269\u6a21\u578b\u4e2d\u7372\u5f97\u6210\u529f\uff0c\u672a\u4f86\u7684\u6280\u8853\u548c\u57fa\u56e0\u9032\u6b65\u53ef\u80fd\u6cbb\u7652\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c5\u60a3\u3002<\/p>\n<p style=\"text-align: justify;\">\u4e94\u3001\u7e3d\u7d50<br \/>\u3000\u3000\u53f0\u7063\u65b0\u751f\u5152\u7be9\u6aa2\uff0c\u5df2\u65bc\u6c11\u570b80\u5e74\u4ee3\u5c07\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7 (CAH)\u52a0\u5165\u5fc5\u9808\u7be9\u6aa2\u9805\u76ee\uff0c\u76ee\u524d\u53f0\u7063\u51fa\u751f\u4e4b\u65b0\u751f\u5152\u5e7e\u4e4e\u70ba\u767e\u5206\u4e4b\u767e\u53d7\u6aa2\u3002\u53f0\u7063\u65b0\u751f\u5152\u7be9\u6aa2\u4e4b\u6548\u7387\u3001\u6db5\u84cb\u7387\u548c\u78ba\u8a3a\u5f8c\u6cbb\u7642\u6210\u6548\uff0c\u4e0d\u8ad6\u662f\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\u6216\u5176\u4ed6\u75be\u75c5\uff0c\u7686\u4e0d\u4e9e\u65bc\u751a\u81f3\u52dd\u904e\u5176\u4ed6\u5148\u9032\u570b\u5bb6\u3002<br \/>\u3000\u3000\u76ee\u524d\u57fa\u56e0\u8a3a\u65b7\u3001\u57fa\u56e0\u6cbb\u7642\u767c\u5c55\u8fc5\u901f\uff0c\u5728\u57fa\u56e0\u8a3a\u65b7\u65b9\u9762\uff0c\u4ee5\u76ee\u524d\u5168\u5916\u986f\u5b50\u5b9a\u5e8f (WES)\/\u5168\u57fa\u56e0\u9ad4\u5b9a\u5e8f (WGS)\u7684\u6548\u7387\uff0c\u5373\u4f7f\u662f\u8a3a\u65b7\u6db5\u84cb\u6240\u6709\u5176\u4ed6\u5c11\u898b\u985e\u578b\u7684\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\u4e5f\u4e0d\u9700\u82b1\u8cbb\u5f88\u9577\u7684\u6642\u9593\uff0c\u57fa\u56e0\u8a3a\u65b7\u7684\u6280\u8853\u4e0d\u65b7\u6539\u826f\uff0c\u6211\u5011\u671f\u5f85\u80fd\u5920\u900f\u904e\u65e9\u671f\u8a3a\u65b7\u3001\u65e9\u671f\u6cbb\u7642\uff0c\u76e1\u91cf\u6e1b\u4f4e\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7\u5c0d\u60a3\u8005\u9020\u6210\u7684\u5f71\u97ff\u3002<br \/>\u3000\u3000WES\/WGS\u5c07\u5168\u9762\u6027\u5354\u52a9\u8a31\u591a\u53ef\u6cbb\u7642\u75be\u75c5\u4e4b\u65e9\u671f\u8a3a\u65b7\uff0c\u5728\u65b0\u751f\u5152\u65b9\u9762\u53ef\u70ba\u9700\u6cbb\u7642\u6216\u8ffd\u8e64\u4e4b\u75be\u75c5\u63d0\u4f9b\u66f4\u5feb\u901f\u7684\u8a3a\u65b7\uff1b\u800c\u57fa\u56e0\u6cbb\u7642\u5c07\u6539\u8b8a\u8a31\u591a\u907a\u50b3\u75be\u75c5\u7684\u6cbb\u7642\u6a21\u5f0f\uff0c\u6211\u5011\u6b63\u7ad9\u5728\u8a31\u591a\u75be\u75c5\u8a3a\u65b7\u548c\u6cbb\u7642\u6a21\u5f0f\u5287\u70c8\u6539\u8b8a\u7684\u98a8\u53e3\uff0c\u672a\u4f86\u4e00\u5b9a\u80fd\u63d0\u4f9b\u75c5\u60a3\u66f4\u4f73\u7684\u9810\u5f8c\u3002<\/p>\n<p style=\"text-align: justify;\">\u8a8c\u8b1d<br \/>\u611f\u8b1d\u8607\u90c1\u6587\u91ab\u5e2b\u7684\u5efa\u8b70<br \/><a href=\"http:\/\/www.cfoh.org.tw\/wp-content\/uploads\/2021\/06\/CAH-1-3.png\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-1691\" src=\"http:\/\/www.cfoh.org.tw\/wp-content\/uploads\/2021\/06\/CAH-1-3.png\" alt=\"\" width=\"439\" height=\"700\" srcset=\"https:\/\/www.cfoh.org.tw\/wp-content\/uploads\/2021\/06\/CAH-1-3.png 439w, https:\/\/www.cfoh.org.tw\/wp-content\/uploads\/2021\/06\/CAH-1-3-188x300.png 188w\" sizes=\"(max-width: 439px) 100vw, 439px\" \/><\/a><\/p>\n<p style=\"text-align: justify;\">\u53c3\u8003\u6587\u737b<br \/>1. Bidet M, Bellanne-Chantelot C, Galand-Portier MB, et al. Fertility in women with non- classical con genital ad re nal hyperplasia due to 21-hydroxylase deficie ncy. J Clin En do- crinol Metab 2010;95:1182-1190.<br \/>2. El-Maouche D, Arlt W, Merke DP. Congenital adrenal hyperplasia. Lancet 2017;390:2194- 2210.<br \/>3. Lee HH. Chimeric CYP21P\/CYP21 and TNXA\/TNXB genes in the RCCX module. Mol Genet Metab2005;84:4-&amp;<br \/>4. Bidet M, Bellanne-Chantelot C, Galand-Portier MB, et al. Clinical and molecular charac- terizati on of a cohort of 161 un related wome n with non classical congen ital adre nal hy- perplasia due to 21-hydroxylase deficiency and 330 family members. J Clin Endocrinol Metab 2009;94:1570-1578.<br \/>5. Fisher AD, Ristori J, Fanni E, Castellini G, Forti G, Maggi M. Gender identity, gender as- signment and reassignment in individuals with disorders of sex development: a major of dilemma. J Endocrinol Invest 2016;39:1207-1224.<br \/>6. Falhammar H, Frisen L, Norrby C, et al. Increased mortality in patients with congen- ital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2014;99:E2715-2721.<br \/>7. White PC. Neonatal screening for congenital ad renal hyperplasia. Nat Rev Endocrinol 2009;5:490-49&amp;<br \/>8. Mallappa A, Sinaii N, Kumar P, et al. A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adre- nal hyperplasia. J Clin Endocrinol Metab 2015;100:1137-1145.<br \/>9. Bryan SM, Honour JW, Hindmarsh PC. Management of altered hydrocortisone pharma- coki netics in a boy with con genital ad re nal hyperplasia using a continuous subcuta ne- ous hydrocortisone infusion. J Clin Endocrinol Metab 2009;94:3477-3480.<br \/>10. Nella AA, Mallappa A, Perritt AF, et al. A phase 2 study of continuous subcutaneous hy- drocortis one infusion in adults with congenital ad renal hyperplasia. J Clin Endocrinol Metab 2016;101:4690-4698.<br \/>11. Balyura M, Gelfgat E, Ehrhart-Bor nstein M, et al. Tran spla ntati on of bovine ad re no corti- cal cells en capsulated in algin ate. Proc Natl Acad Sci U S A 2015;112:2527-2532.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u81fa\u5317\u69ae\u6c11\u7e3d\u91ab\u9662 \u5152\u7ae5\u907a\u50b3\u5167\u5206\u6ccc\u79d1 \u694a\u4f73\u9cf3 \u91ab\u5e2b\u81fa\u5317\u69ae\u6c11\u7e3d\u91ab\u9662 \u5167\u5206\u6ccc\u65b0\u9673\u4ee3\u8b1d\u79d1 \u6797\u5b8f\u9054 \u91ab\u5e2b\u672c &#8230; <a title=\"\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7 (CAH) \u81e8\u5e8a\u6848\u4f8b\u5206\u4eab\" class=\"read-more\" href=\"https:\/\/www.cfoh.org.tw\/index.php\/nbs\/case\/case-2\/\" aria-label=\"\u95b1\u8b80\u3008\u5148\u5929\u6027\u814e\u4e0a\u817a\u589e\u751f\u75c7 (CAH) \u81e8\u5e8a\u6848\u4f8b\u5206\u4eab\u3009\u5168\u6587\">\u95b1\u8b80\u5168\u6587<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"parent":1660,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"jetpack_post_was_ever_published":false,"footnotes":""},"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/P9uzrk-re","_links":{"self":[{"href":"https:\/\/www.cfoh.org.tw\/index.php\/wp-json\/wp\/v2\/pages\/1688"}],"collection":[{"href":"https:\/\/www.cfoh.org.tw\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cfoh.org.tw\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cfoh.org.tw\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cfoh.org.tw\/index.php\/wp-json\/wp\/v2\/comments?post=1688"}],"version-history":[{"count":1,"href":"https:\/\/www.cfoh.org.tw\/index.php\/wp-json\/wp\/v2\/pages\/1688\/revisions"}],"predecessor-version":[{"id":1692,"href":"https:\/\/www.cfoh.org.tw\/index.php\/wp-json\/wp\/v2\/pages\/1688\/revisions\/1692"}],"up":[{"embeddable":true,"href":"https:\/\/www.cfoh.org.tw\/index.php\/wp-json\/wp\/v2\/pages\/1660"}],"wp:attachment":[{"href":"https:\/\/www.cfoh.org.tw\/index.php\/wp-json\/wp\/v2\/media?parent=1688"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}